Search research articles
Contact Us
Filters
Showing results (31-40 of 353) with videos related to
Page
of 36
Sort By:
Oncology (Williston Park, N.Y.)
|
April 1, 2000
High-dose therapy for follicular lymphoma
A Freedman, J W Friedberg, J Gribben
BMC Medical Research Methodology
|
August 16, 2019
Dynamic risk prediction for diabetes using biomarker change measurements
Layla Parast, Megan Mathews, Mark W Friedberg
Blood
|
December 16, 2014
Transformed follicular non-Hodgkin lymphoma
Carla Casulo, W Richard Burack, Jonathan W Friedberg
The American Journal of Managed Care
|
March 17, 2009
Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?
Mark W Friedberg, Ateev Mehrotra, Jeffrey A Linder
Ejhaem
|
November 29, 2023
Current directions in the treatment of classical Hodgkin lymphoma
Frank G Keller, Brad Kahl, Jonathan W Friedberg
Lancet (London, England)
|
January 25, 2021
Classical Hodgkin lymphoma
Pauline Brice, Eric de Kerviler, Jonathan W Friedberg
Oncology (Williston Park, N.Y.)
|
April 3, 2007
Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma
Julia Schaefer-Cutillo, Jonathan W Friedberg, Richard I Fisher
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
December 24, 2011
Health information exchange, Health Information Technology use, and hospital readmission rates
Spencer S Jones, Mark W Friedberg, Eric C Schneider
Health Affairs (Project Hope)
|
May 5, 2010
Primary care: a critical review of the evidence on quality and costs of health care
Mark W Friedberg, Peter S Hussey, Eric C Schneider
Clinical Advances in Hematology & Oncology : H&O
|
August 18, 2010
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy
Brad S Kahl, Bruce D Cheson, Jonathan W Friedberg
Page
of 36
Search research articles
Search
Showing results (31-40 of 353) with videos related to
Sort By:
Page
of 36
Oncology (Williston Park, N.Y.)
|
April 1, 2000
High-dose therapy for follicular lymphoma
A Freedman, J W Friedberg, J Gribben
BMC Medical Research Methodology
|
August 16, 2019
Dynamic risk prediction for diabetes using biomarker change measurements
Layla Parast, Megan Mathews, Mark W Friedberg
Blood
|
December 16, 2014
Transformed follicular non-Hodgkin lymphoma
Carla Casulo, W Richard Burack, Jonathan W Friedberg
The American Journal of Managed Care
|
March 17, 2009
Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?
Mark W Friedberg, Ateev Mehrotra, Jeffrey A Linder
Ejhaem
|
November 29, 2023
Current directions in the treatment of classical Hodgkin lymphoma
Frank G Keller, Brad Kahl, Jonathan W Friedberg
Lancet (London, England)
|
January 25, 2021
Classical Hodgkin lymphoma
Pauline Brice, Eric de Kerviler, Jonathan W Friedberg
Oncology (Williston Park, N.Y.)
|
April 3, 2007
Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma
Julia Schaefer-Cutillo, Jonathan W Friedberg, Richard I Fisher
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
December 24, 2011
Health information exchange, Health Information Technology use, and hospital readmission rates
Spencer S Jones, Mark W Friedberg, Eric C Schneider
Health Affairs (Project Hope)
|
May 5, 2010
Primary care: a critical review of the evidence on quality and costs of health care
Mark W Friedberg, Peter S Hussey, Eric C Schneider
Clinical Advances in Hematology & Oncology : H&O
|
August 18, 2010
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy
Brad S Kahl, Bruce D Cheson, Jonathan W Friedberg
Page
of 36